Chitnis is using a unique blend of clinical trials, genomic studies and personalized medicine to improve care for patients with multiple sclerosis at all ages.
Blog
Farrah Mateen, MD, PhD Multiple sclerosis (MS) is not your average neurological disorder. For one thing, it tends to strike patients at a much younger age than most cases of Alzheimer’s disease or Parkinson’s disease. In fact, it is the leading non-traumatic cause of disability in young adults in the United States. For another, eachRead more
Mass General researcher are investigating the impact of light therapy on fatigue related to multiple sclerosis (MS).